Chargin Amanda, Yin Fangfang, Song Min, Subramaniam Srividyabhuvaneswari, Knutson Grace, Patterson Bruce K
IncellDx, Inc., Menlo Park, California, USA.
IncellDx, Inc., Menlo Park, California, USA
J Clin Microbiol. 2015 Jan;53(1):60-6. doi: 10.1128/JCM.02539-14. Epub 2014 Oct 22.
Plasma viral load and CD4 counts are effective for clinical monitoring, but they do not give a full representation of HIV-1 quasispecies in cellular reservoirs, the major repository of replication-competent HIV-1 in infected individuals. We sought to develop a diagnostic system that might stimulate the replication-competent HIV-1 reservoirs for enhanced clinical monitoring, including selection of antiretroviral regimens. Whole-blood samples from 45 HIV-infected individuals were collected into 1 ViraStim HIV-1 activation tube and 1 EDTA tube. Samples were tested for viral load and cell type-specific HIV-1 replication. Further, 7 matched activated/nonactivated samples were sequenced using the Trugene HIV-1 genotyping kit. The percentage of patients with replication-competent virus in peripheral blood mononuclear cells (PBMCs) varied, depending on the baseline plasma viral load in the EDTA tubes. Six out of 24 patients with a starting plasma viral load of <20 copies/ml (cp/ml), 6 out of 8 patients with starting viral loads of >20 and <1,000 cp/ml, and 8 out of 13 patients with starting viral loads of >1,000 all showed increases in viral replication of >5-fold. These increases came from cellular reservoirs in blood as determined by simultaneous ultrasensitive subpopulation staining/hybridization in situ (SUSHI). When resistance genotypes in plasma from activation tubes were compared to those from EDTA tubes for 7 patients, all patients showed additional mutations in the activation tube, while 3 patients demonstrated additional genotypic resistance determinants. We show that HIV-1 viral replication can be stimulated directly from infected whole blood. The sequencing results showed that 3 of 7 cases demonstrated additional drug resistance following stimulation.
血浆病毒载量和CD4细胞计数对临床监测有效,但它们不能全面反映细胞储存库中的HIV-1准种,而细胞储存库是受感染个体中具有复制能力的HIV-1的主要储存场所。我们试图开发一种诊断系统,该系统可能刺激具有复制能力的HIV-1储存库,以加强临床监测,包括抗逆转录病毒治疗方案的选择。将45名HIV感染者的全血样本收集到1个ViraStim HIV-1激活管和1个EDTA管中。对样本进行病毒载量和细胞类型特异性HIV-1复制检测。此外,使用Trugene HIV-1基因分型试剂盒对7对匹配的激活/未激活样本进行测序。外周血单核细胞(PBMC)中具有复制能力病毒的患者百分比各不相同,这取决于EDTA管中的基线血浆病毒载量。起始血浆病毒载量<20拷贝/毫升(cp/ml)的24名患者中有6名,起始病毒载量>20且<1000 cp/ml的8名患者中有6名,起始病毒载量>1000的13名患者中有8名,其病毒复制均增加了>5倍。这些增加来自血液中的细胞储存库,这是通过同时进行超敏亚群染色/原位杂交(SUSHI)确定的。当比较7名患者激活管血浆中的耐药基因型与EDTA管中的耐药基因型时,所有患者在激活管中均显示出额外的突变,而3名患者表现出额外的基因型耐药决定因素。我们表明,HIV-1病毒复制可以直接从受感染的全血中被刺激。测序结果显示,7例中有3例在刺激后表现出额外的耐药性。